Review
doi: 10.1111/j.1445-2197.1998.tb04805.x.
Modern aspects of prophylaxis and therapy for venous thrombo-embolic disease
Affiliations
- PMID: 9669358
- DOI: 10.1111/j.1445-2197.1998.tb04805.x
Item in Clipboard
Review
Modern aspects of prophylaxis and therapy for venous thrombo-embolic disease
Aust N Z J Surg.
1998 Jul.
No abstract available
Similar articles
-
Ardeparin and danaparoid for prevention of deep vein thrombosis.Med Lett Drugs Ther. 1997 Oct 10;39(1011):94-5. Med Lett Drugs Ther. 1997. PMID: 9379998 No abstract available.
-
New antithrombotic agents for the prevention and treatment of deep vein thrombosis.Haemostasis. 1996 Oct;26 Suppl 4:368-78. doi: 10.1159/000217318. Haemostasis. 1996. PMID: 8979141 Review.
-
[Clinical experience with Danaparoid-sodium: measures to be taken in heparin-induced thrombocytopenia].Chirurg. 1998 Nov;69(11 Suppl Massnahme):1-4. Chirurg. 1998. PMID: 9853175 German. No abstract available.
-
Prophylaxis of venous thromboembolism in stroke patients.Semin Thromb Hemost. 1997;23(2):155-7. doi: 10.1055/s-2007-996084. Semin Thromb Hemost. 1997. PMID: 9200340
-
Ardeparin and danaparoid.Dimens Crit Care Nurs. 2000 Jul-Aug;19(4):13-4. doi: 10.1097/00003465-200019040-00004. Dimens Crit Care Nurs. 2000. PMID: 11998151 Review. No abstract available.
Cited by
-
Dalteparin: an update of its pharmacological properties and clinical efficacy in the prophylaxis and treatment of thromboembolic disease.Drugs. 2000 Jul;60(1):203-37. doi: 10.2165/00003495-200060010-00010. Drugs. 2000. PMID: 10929935 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
